MedPath

Liquid Nutritional Supplement on Malnutrition Hospitalized Patient

Not Applicable
Conditions
Malnutrition
Interventions
Dietary Supplement: Placebo
Dietary Supplement: Liquid Nutritional Supplement from Hospital Product
Registration Number
NCT04036825
Lead Sponsor
Fakultas Kedokteran Universitas Indonesia
Brief Summary

The aim of this study is to know the effectivity of liquid nutritional supplementation in malnutrition hospitalized patients

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
138
Inclusion Criteria
  • aged ≥ 18 years old to 60 years old
  • malnutrition hospitalized patient based on European Society for Clinical Nutrition and Metabolism (ESPEN) 2015 criteria
  • agreed to participate
Exclusion Criteria
  • malignancy
  • chronic kidney disease stage III-V
  • decompensated hepatic cirrhosis
  • allergic to milk or lactose intolerance
  • could not be randomised and participate in this study by clinical judgement

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PlaceboPlaceboThis group received standard liquid nutritional supplement as a placebo. Placebo will be given 2 times daily for 14 days
Liquid Nutritional Supplement from Hospital ProductLiquid Nutritional Supplement from Hospital ProductThis group received liquid nutritional supplement from hospital product. The product is in a form of low lactose milk ready to drink with volume 200 ml and will be given 2 times daily for 14 days. This product is consist of 1.017 kcal/ml, 10 vitamin and 9 mineral
Primary Outcome Measures
NameTimeMethod
Change of Body Mass Index (BMI)0 and 14 days

BMI was assessed from height and body calculation. Classification of BMI is based on World Health Organization (WHO) classification.

Secondary Outcome Measures
NameTimeMethod
Change of Subjective Global Assessment (SGA) rank0 and 14 days

SGA rank is classified to A (well nourished), B (moderately malnourished) and C (severely malnourished) and these option are chosen based on history and physical examination that are stated in the SGA form.

Change of body fat percentage0 and 14 days

Body fat percentage is assessed by Bioelectrical Impedance Analysis (BIA)

Change of handgrip strength test score0 and 14 days

Handgrip strength is assessed by handgrip strength score.

Change of hemoglobin level0 and 14 days

Hemoglobin level is obtain from laboratory test

Change of prealbumin level0 and 14 days

Prealbumin level is obtain from laboratory test

Change of lipid profile level0 and 14 days

Lipid profile level is obtain from laboratory test

Change of blood glucose level0 and 14 days

Blood glucose level is obtain from laboratory test

Change of Blood Urea Nitrogen (BUN) level0 and 14 days

BUN level is obtain from laboratory test

Trial Locations

Locations (1)

RSUPN dr. Cipto Mangunkusumo (Cipto Mangunkusumo Hospital)

🇮🇩

Jakarta Pusat, Indonesia

© Copyright 2025. All Rights Reserved by MedPath